Prognostic factors for hepatocellular carcinoma recurrence: Experience with 83 liver transplantation patients

Transplantation Proceedings

Volumn 43, Issue 4, 2011, Pages 1362-1364

  Ataide, E C ^a   Boin, I F S F ^a   Almeida, J R S ^a   Seva Pereira T ^a   Stucchi, R S B ^a   Cardoso, A R ^a   Caruy, C A A ^a   Escanhoela, C A F ^a  

^a UNIVERSITY OF CAMPINAS   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA FETOPROTEIN;

ADULT; CANCER INVASION; CANCER MORTALITY; CANCER RECURRENCE; CANCER RELAPSE; CANCER SURVIVAL; CHEMOEMBOLIZATION; COHORT ANALYSIS; CONFERENCE PAPER; EXPLANT; FEMALE; HUMAN; INCIDENTAL FINDING; LIVER CELL CARCINOMA; LIVER NODULE; LIVER TRANSPLANTATION; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; RETROSPECTIVE STUDY; TUMOR DIFFERENTIATION; TUMOR VOLUME;

ADOLESCENT; ADULT; AGED; BRAZIL; CARCINOMA, HEPATOCELLULAR; FEMALE; HUMANS; KAPLAN-MEIER ESTIMATE; LIVER NEOPLASMS; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM STAGING; PROPORTIONAL HAZARDS MODELS; RECURRENCE; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; SURVIVAL RATE; TIME FACTORS; TREATMENT OUTCOME; TUMOR BURDEN; YOUNG ADULT;

EID: 79957611926     PISSN: 00411345     EISSN: 18732623     Source Type: Journal    
DOI: 10.1016/j.transproceed.2011.02.032     Document Type: Conference Paper

References (12)

1. Zavaglia C, De Carlis L, Alberti AB, et al: Predictors of long-term survival after liver transplantation for hepatocellular carcinoma. Am J Gastroenterol 100:2708, 2005
2. Shah Sa, Tan JCC, McGilvray ID, et al: Does microvascular invasion affect outcomes after liver transplantation for hcc? a histopathological analysis of 155 consecutive explants. Gastrointest Surg 11:464, 2007
3. Sumie S, Kuromatsu R, Okuda K, et al: Microvascular invasion in patients with hepatocellular carcinoma and its predictable clinicopathological factors. Ann Surg Oncol 15:1375, 2008
4. Parfitt JR, Marotta P, AlGhamdi M, et al: Recurrent hepatocellular carcinoma after transplantation: use of a pathological score on explanted livers to predict recurrence. Liver Transpl 13:543, 2007
5. Tsoulfas G, Kawai T, Elias N: Long-term experience with liver transplantation for hepatocellular carcinoma. J Gastroenterol 46:249, 2010
6. Mazzaferro V, Llovet JM, Miceli R, et al: Metroticket Investigator Study Group. Predicting survival after liver transplantation in patients with hepatocellular carcinoma beyond the Milan criteria: a retrospective, exploratory analysis. Lancet Oncol 10:35, 2009
7. Boin IF, Pracucho EM, Rique MC, et al: Expanded Milan criteria on pathological examination after liver transplantation: analysis of preoperative data. Transplant Proc 40:777, 2008
8. Freeman RB, Mithoefer A, Ruthazer R, et al: Optimizing staging for hepatocellular carcinoma before liver transplantation: a retrospective analysis of the UNOS/OPTN databse. Liver Transpl 12:1504, 2006
9. Yamamoto K, Imamura H, Matsuyama Y, et al: AFP, AFPL3, DCP, and GP73 as markers for monitoring treatment response and recurrence and as surrogate markers of clinicopathological variables of HCC. J Gastroenterol 45:1272, 2010
10. Zimmerman MA, Ghobrial M, Tong MJ: Recurrence of hepatocellular carcinoma following liver transplantation - a review of preoperative and postoperative prognostic indicators. Arch Surg 143:182, 2008
11. Zhou YM, Yang JM, Li B, et al: Risk factors for early recurrence of small hepatocellular carcinoma after curative resection. Hepatobiliary Pancreat Dis Int 9:33, 2010
12. Roayaie S, Blume IN, Thung SN, et al: A system of classifying microvascular invasion to predict outcome after resection in patients with hepatocellular carcinoma. Gastroenterology 137:850, 2009